Journals / Molecular Oncologic Imaging / 2022 / Cilt: 2 - Sayı: 3

Treatment Response Evaluation by F-18 FDG PET/CT in Radioiodine Refractory Differentiated Carcinoma in a Case with Multiple Unusual Metastatic Lesions

Pages
52–55
DOI
—

Abstract

F-18 FDG PET/CT has a documented role in diagnosis of the patients with radioiodine refractory differentiated thyroid carcinoma (RAIR-DTC) and there are ongoing studies about the treatment response evaluation for tyrosine kinase inhibitor treatment response evaluation. This case report is about the treatment response evaluation of a unique patient with multiple unusual metastatic lesions of RAIR-DTC.